AzTrials
AzTrials

Healthy IndividualsLÄRMNCT02783456

The Influence of Aircraft Noise Exposure on Renal Hemodynamic in Healthy Individuals

A study testing Noise and Silence in people with Healthy Individuals and Arterial Hypertension, run by University of Erlangen-Nürnberg Medical School at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Epidemiological studies have found a link between aircraft noise exposure and increased incidence of arterial hypertension and thus cardiovascular disease. The underlying pathophysiological mechanisms are not yet fully understood. Read more about this study

Who is it for?
Ages 18 to 50 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy Individuals, Arterial Hypertension
What is being tested?
Noise and Silence
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
1 siteGermany
Study dates
Mar 2016to Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with mild-moderate arterial hypertension (grade 1-2)
  • Informed consent in writing available
  • Willing and able to comply with all requirements of the study
  • Male, between 18 and 50 years (inclusive)
  • Body Mass Index (BMI) 18-27 kg/m2
  • Non-smoker
Show all 10Show fewer
  • Good general health as judged by the Investigator, as determined by medical history, physical examination, vital signs (systolic and diastolic blood pressure and pulse rate) and clinical laboratory parameters (clinical chemistry, hematology, and urinalysis).
  • Minor deviations of laboratory values, ECG, and vital sign parameters from the normal range may be accepted, if judged by the Investigator to have no clinical relevance.
  • Additional inclusion criteria for the cohort with arterial hypertension:
  • uncomplicated arterial hypertension WHO grade 1-2, office blood pressure 140-179/90-109 mmHg

Who cannot join

  • Clinically significant abnormalities in physical examination, vital signs or clinical laboratory parameters (according to the Investigator's judgement).
  • S-GOT or S-GPT levels > 2-times above the upper limit of normal range.
  • eGFR < 60 ml/min/1,73m2 or kidney stones
  • Clinically significant history of cardiovascular disease or any known present cardiovascular disease.
  • History of clinically significant neurological, gastrointestinal, renal, hepatic, psychological, pulmonary, metabolic, endocrine, hematological, or other major disorders.
  • Office blood pressure at screening higher than 140/100 mmHg
Show all 26Show fewer
  • Office heart rate at screening outside the range of 50-99 beats per minute (inclusive).
  • Regular intake of medication within 1 month prior to study inclusion
  • Participation in any other clinical study within 30 days prior to inclusion in this study.
  • Clinically significant diseases (as judged by the investigator) within four weeks prior to screening
  • History of alcohol or drug abuse.
  • Regular intake of medication within 1 month prior to study inclusion
  • office blood pressure at screening visit > 180/110 mmHg
  • secondary hypertension application of
  • antihypertensive medication within 14 days prior to study inclusion
  • of "other" medication
  • Clinically significant abnormalities in physical examination, vital signs or clinical laboratory parameters (according to the Investigator's judgement).
  • S-GOT or S-GPT levels > 2-times above the upper limit of normal range.
  • eGFR < 60 ml/min/1,73m2 or kidney stones
  • Clinically significant history of cardiovascular disease or any known present cardiovascular disease other than arterial hypertension.
  • History of clinically significant neurological, gastrointestinal, renal, hepatic, psychological, pulmonary, metabolic, endocrine, hematological, or other major disorders, other than arterial hypertension.
  • Office heart rate at screening outside the range of 50-99 beats per minute (inclusive).
  • Regular intake of medication within 1 month prior to study inclusion
  • Participation in any other clinical study within 30 days prior to inclusion in this study.
  • Clinically significant diseases (as judged by the investigator) within four weeks prior to screening, other than arterial hypertension.
  • History of alcohol or drug abuse.

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University of Erlangen-Nuremberg

    Erlangen, Bavaria, 91054

Other trials in Germany

About this study

Epidemiological studies have found a link between aircraft noise exposure and increased incidence of arterial hypertension and thus cardiovascular disease. The underlying pathophysiological mechanisms are not yet fully understood. The kidney acts as a long-term regulator of blood pressure and controls the extracellular sodium and water balance. Significant renal mechanisms of blood pressure regulation are the renin angiotensin system, renal sympathetic activity and sodium excretion. Animal work and clinical studies show that mental stress affects the renal plasma flow and urinary sodium excretion. The investigators observed a lower sodium excretion in situations of mental stress in subjects at risk for developing arterial hypertension. In healthy volunteers, a 30-minute mental stress test resulted in increased glomerular filtration rate, filtration fraction and an increase in urinary sodium excretion. In this pilot study the investigators analyzed the influence of 30 minutes standardized aircraft noise on renal and central hemodynamics.

Read the detailed description

The World Health Organisation (WHO) estimates that (about 340 million population) 1 million annually health life years are lost by environmental noise exposure in high-income countries of Western Europe. Aircraft noise is thereby assessed at comparable volume as unpleasant as road and rail noise. Epidemiological studies have found a link between aircraft noise exposure and increased incidence of arterial hypertension and thus cardiovascular disease. The underlying pathophysiological mechanisms are not yet fully understood.

The kidney acts as a long-term regulator of blood pressure and controls the extracellular sodium and water balance. Significant renal mechanisms of blood pressure regulation are the renin angiotensin system, renal sympathetic activity and sodium excretion. Animal work and clinical studies show that mental stress affects the renal plasma flow and urinary sodium excretion. In spontaneously hypertensive rats environmental stress resulted in sodium retention, triggered by increased renal sympathetic nerve activity, which is the development of arterial hypertension. In a pilot study in subjects at risk for developing arterial hypertension, the investigator observed a lower sodium excretion by mental stress. In healthy volunteers, a 30-minute mental stress test resulted in increased glomerular filtration rate, filtration fraction and an increase in urinary sodium excretion.

In the rabbit noise exposure leads to an increase of frequency and amplitude of discharges of renal sympathetic nerve activity and accompanied by a reduction of renal plasma flow. The impact of aircraft noise on renal plasma flow and urinary sodium excretion has, to our knowledge, so far not been studied in humans.

In this pilot study the Clinical Research Center investigate the influence of 30 minutes standardized aircraft noise on renal hemodynamics.

Hemodynamic renal changes should be considered in the context of the systemic circulation. Therefore, the central hemodynamics is determined in the present pilot study by bioimpedance cardiography.

Being tested
Noise, Silence
Keywords
renal hemodynamic, central hemodynamic, pilot study, flight noise, healthy participant, renal plasma flow, filtration fraction, renal vascular resistance, calculated intra glomerular pressure
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NoiseProcedure or surgery

    The patient is exposed 30 min to the first sound pattern and during the renal hemodynamics will be measured. The following is a 1-hour break.

  • SilenceProcedure or surgery

    The patient is exposed 30 min to the second sound pattern and during the renal hemodynamics will be measured.

Study groups in NCT02783456
Study groupRoleWhat they receive
Noise and silenceActive comparatorExposition of 80dB flight noise for 30 minutes and 30 minutes silence.
Receives: Procedure: Noise; Procedure: Silence
silence and noiseActive comparatorExposition of 30 minutes silence.and 80dB flight noise for 30 minutes
Receives: Procedure: Noise; Procedure: Silence

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in renal plasma flow (l/min)

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 May 2016 (estimated)
  2. Study startMar 2016
  3. Primary completionJan 2018
  4. Study completionJan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Care provider
Enrolment
86 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02783456
Sponsor's protocol ID
CRCLÄRM2016
Acronym
LÄRM
Status last verified
Feb 2018
First submitted
27 Apr 2016
Last updated
26 Feb 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • A. Jumar, C. Ott, J.M. Harazny, K. Striepe, M.V. Karg, R.E. Schmieder. NEW MODEL TO INVESTIGATE THE INFLUENCE OF AIRCRAFT NOISE IN THE PATHOPHYSIOLOGICAL CONCEPT OF HYPERTENSION J Hypertens 2017;35, e-Supplement 2:e214 PP.15.32

  • Bosch A, Rauh M, Striepe K, Schiffer M, Schmieder RE, Kannenkeril D. Renal adaptation in pre-obesity patients with hypertension. J Hypertens. 2024 Nov 1;42(11):1958-1965. doi: 10.1097/HJH.0000000000003821. Epub 2024 Jul 19.

    PubMed 39248112

Questions about this trial

What is this clinical trial studying?

A study testing Noise and Silence in people with Healthy Individuals and Arterial Hypertension, run by University of Erlangen-Nürnberg Medical School at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 26 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in renal plasma flow (l/min) (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02783456, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in